Gregory Scott Duncan is CEO at Virios Therapeutics, Inc. (VIRI). They have made 4 open-market trades across 1 company since 2021, most recently 2026-01-26.
CIK 0001831127
4 open-market purchases totalling $289K since 2021, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| VIRI | BUY | 2023-08-17 | 2023-08-18 | $1.25 | $31K | -5.4% | -20.9% | -43.4% |
| VIRI | BUY | 2022-05-23 | 2022-05-24 | $4.52 | $34K | +11.6% | +6.3% | +62.3% |
| VIRI | BUY | 2021-12-21 | 2021-12-22 | $5.52 | $28K | +0.5% | +15.7% | -3.0% |
| VIRI | BUY | 2021-04-06 | 2021-04-07 | $6.36 | $2K | -10.4% | -21.0% | +2.8% |
| VIRI | BUY | 2021-04-05 | 2021-04-06 | $6.17 | $193K | -11.6% | -22.3% | +1.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.